In cancer research, omentin induces cancer cell proliferation by activating genomic instability and the PI3K/Akt (phosphatidylinositol-3-kinase downstream effector) signaling pathway, suggesting that omentin's cancer-promoting effects were independent of its ability to reduce metabolic risk from obesity [13]. The gene discussed is AKT1; the disease is obesity disorder.